Speakers: Dr Michelle Hui, Consultant Rheumatologist (UHDB) and Dr Antonia Ugur, Consultant Endocrinologist (UHDB)

Session Objectives:

• Identify key updates since the last JAPC osteoporosis guidelines and rationale behind these changes
• Explain reasons for and against the use of denosumab in light of emerging evidence
• Outline reasons for referral to the osteoporosis service in secondary care
• Provide an update regarding treatment breaks and the evidence behind these

Register in advance for this meeting:

https://us02web.zoom.us/meeting/register/tZ0kf-itqzkrGtIE6p3qt09syjLIzdcYCRto

After registering, you will receive a confirmation email containing information about joining the meeting.

Sponsored by Chiesi Ltd

A list of attendee names will be sent to sponsors.